Racial/ethnic differences of germline pathogenic variants in cancer susceptibility genes among patients with early-onset colorectal cancer.

Authors

Andreana Holowatyj

Andreana N Holowatyj

Vanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center, Nashville, TN;

Andreana N Holowatyj , Hannah M Seagle , Samantha Keller , Sean V Tavtigian , David E Goldgar , Carolyn Horton

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Cancer Disparities

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 19)

DOI

10.1200/JCO.2023.41.4_suppl.19

Abstract #

19

Poster Bd #

A14

Abstract Disclosures

Similar Posters

Poster

2017 ASCO Annual Meeting

Expanded yield of multiplex panel testing in fully accrued prospective trial.

Expanded yield of multiplex panel testing in fully accrued prospective trial.

First Author: Gregory Idos

Poster

2023 ASCO Annual Meeting

Spectrum of germline pathogenic variants among patients with cancer in Mexico.

Spectrum of germline pathogenic variants among patients with cancer in Mexico.

First Author: Jose Luis Rodriguez Olivares

Poster

2022 ASCO Gastrointestinal Cancers Symposium

Germline pathogenic variants among Mexican patients with adenocarcinoma of the pancreas.

Germline pathogenic variants among Mexican patients with adenocarcinoma of the pancreas.

First Author: Jose Luis Rodriguez Olivares

Poster

2020 ASCO Virtual Scientific Program

Development and validation of the PREMMplus clinical prediction model for multigene hereditary cancer risk assessment.

Development and validation of the PREMMplus clinical prediction model for multigene hereditary cancer risk assessment.

First Author: Matthew B. Yurgelun